KCT0000009已完成未知
Efficacy and Safety of Paliperidone in Patients With First Episode Psychosis: an Open-label, Prospective Multi-center Study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 59(Year)（—）
- 性别
- All
入选标准
- •Aged 18-59 years and meet DSM-IV diagnostic criteria for first episode of schizophrenia, schizophreniform disorder, schizoaffective disorder or psychotic disorder NOS as assessed by using the Structured Clinical Interview for DSM-IV, research version.
排除标准
- •Meeting DSM-IV criteria for another axis I diagnosis, including substance abuse or dependence
- •Needing another nonantipsychotic psychotropic medication at enrollment
- •Having a serious or unstable medical illness.
- •Pregnant or lactating women or women without adequate contraception will be also excluded.
研究者
相似试验
已完成
不适用
Safety and efficacy of lenalidomide for patients with relapsed or refractory adult T cell leukemia/lymphoma post allogeneic hematopoietic stem cell transplantation, multi-institutional prospective observational trialAdult T-cell leukemia-lymphomaJPRN-UMIN000029635Kagoshima University33
进行中（未招募）
不适用
Effect of Neurodoron in patients with nervous exhaustionervous exhaustion (neurasthenia)MedDRA version: 14.0Level: LLTClassification code 10029200Term: Nervous exhaustionSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2010-024189-23-DEWeleda AG
已完成
4 期
Efficacy and safety of Neurodoron in patients with nervous exhaustion – a randomized, double-blind, placebo-controlled clinical trial –F48.0NeurastheniaDRKS00003261WELEDA AGBereich Medizin/Medical Affairs204
已完成
2 期
An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With SchizophreniaSchizophreniaNCT00257023Janssen Pharmaceutical K.K.52
已完成
4 期
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute SchizophreniaSchizophreniaNCT01527305Janssen Research & Development, LLC212